India Still Viable for Drug Innovation, Hisey Says

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Are Cloud Robotics Are a Game-Changer?
30:50 - “The Industries of the Future” Author Alec Ross discusses cloud robotics and the future of robot technology on “Bloomberg West.” (Source: Bloomberg)
  • Is There a Tech Talent Shortage in Silicon Valley?
  • Blackberry Cuts Jobs in Push to Profit
  • Bloomberg Businessweek: The Female Solidarity